Transthyretin amyloid polyneuropathy in France: A cross-sectional study with 413 patients and real-world tafamidis meglumine use (2009-2019).

D AdamsP CintasG SoléC TardC LabeyrieA Echaniz-LagunaC CauquilY PereonL MagyR Juntas MoralesJ C AntoineE LagrangeP PetiotM MallaretB FrancouA Guiochon-MantelA CosteO DemarcqC GeffroyV FamelartJ RudantM BartoliE DonalO LairezJ C EicherM KharoubiS OghinaJ N TrochuJ InamoG HabibF RoubilleA HagègeF MorioE CariouJ AddaM S SlamaP CharronV AlgalarrondoT DamyS Attarian

Published in: Revue neurologique (2024)

In France, ATTRv patients are usually identified early thanks to the national network and the help of diagnosis combining genetic testing and mini-invasive biopsies.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
physical activity
risk factors
patient reported outcomes
quality improvement
wild type